AHA 2023 Michael Lincoff shares the results of the SELECT trial. “This trial is the first to show a weight-management therapy in a rigorous randomized trial to reduce the risk of CV events associated with overweight and obesity, and now positions overweight and obesity as a modifiable risk factor for CVD” said Lincoff.
ReachMD
Be part of the knowledge.™Register
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?
GLP-1RA reduces risk of CV events associated with overweight and obesity
Restart
Resume
Share this program on:
Choose a format
Media formats available:
Completing the pre-test is required to access this content.
Completing the pre-survey is required to view this content.
Details
Presenters
Comments
Overview
Educational information
This video was recorded during the AHA Scientific Sessions 2023 in Philadelphia, PA, USA.
Faculty
Michael Lincoff, MD is an interventional cardiologist and Vice Chairman for Research of the Department of Cardiovascular Medicine at the Cleveland Clinic in Cleveland, OH, USA. He is also the Director of the Cleveland Clinic Coordinating Center for Clinical Research.
Disclosures
This recording was developed under auspices of PACE-CME. Views expressed in the recording are those of the presenter and do not necessarily reflect the views of PACE-CME.
Read a summary of the SELECT trial
The information and data provided in this program were updated and correct at the time of the program development, but may be subject to change.
Presenters
Recommended
Details
Presenters
Comments
Recommended
Overview
AHA 2023 Michael Lincoff shares the results of the SELECT trial. “This trial is the first to show a weight-management therapy in a rigorous randomized trial to reduce the risk of CV events associated with overweight and obesity, and now positions overweight and obesity as a modifiable risk factor for CVD” said Lincoff.
Educational information
This video was recorded during the AHA Scientific Sessions 2023 in Philadelphia, PA, USA.
Faculty
Michael Lincoff, MD is an interventional cardiologist and Vice Chairman for Research of the Department of Cardiovascular Medicine at the Cleveland Clinic in Cleveland, OH, USA. He is also the Director of the Cleveland Clinic Coordinating Center for Clinical Research.
Disclosures
This recording was developed under auspices of PACE-CME. Views expressed in the recording are those of the presenter and do not necessarily reflect the views of PACE-CME.
Read a summary of the SELECT trial
The information and data provided in this program were updated and correct at the time of the program development, but may be subject to change.
Presenters
Facebook Comments